NEW YORK--(BUSINESS WIRE)--The New York Academy of Sciences (NYAS) and Halloran Consulting Group (HCG) are collaborating to deliver a comprehensive executive seminar on clinical development in the increasingly complex global biotech and biopharmaceutical marketplaces. Part of NYAS’ Idea to IPO Learning Series, the C-Level Clinical Development course will focus on strategic development planning, the global regulatory environment and conducting high quality and capitally efficient clinical research.
